Medicine & Life Sciences
Oxaliplatin
100%
Hyperalgesia
67%
Peripheral Nervous System Diseases
66%
Retrospective Studies
28%
gosha-jinki-gan
26%
Anxiety
23%
Japan
23%
Cyclophosphamide
19%
Doxorubicin
19%
Receptor, Serotonin, 5-HT2A
18%
Lipopolysaccharides
18%
Bortezomib
17%
Diazepam
15%
Cold Temperature
15%
Duloxetine Hydrochloride
15%
Neurites
14%
Pharmaceutical Preparations
14%
Pharmacists
13%
Anti-Anxiety Agents
13%
Receptor, Serotonin, 5-HT1A
13%
Neoplasms
13%
Therapeutics
12%
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
12%
bu-zhong-yi-qi-tang
12%
neurotropin
12%
Lubiprostone
12%
Multicenter Studies
12%
Duration of Therapy
12%
cefozopran
12%
Magnesium Oxide
12%
NR2B NMDA receptor
11%
lenvatinib
11%
Drug Therapy
11%
nafamostat
11%
Paclitaxel
11%
PC12 Cells
11%
Albumin-Bound Paclitaxel
11%
Axitinib
11%
Valganciclovir
10%
Sciatic Nerve
10%
edoxaban
10%
Riluzole
10%
mouse interleukin-6
10%
Serotonin and Noradrenaline Reuptake Inhibitors
10%
Big Data
10%
Pharmacovigilance
10%
Amitriptyline
9%
Neuregulin-1
9%
Self Stimulation
9%
Righting Reflex
9%
Chemical Compounds
Oxaliplatin
38%
Safety
18%
Duloxetine
16%
Drug
15%
Vonoprazan
14%
Cefozopran
14%
Noradrenalin Uptake Inhibitor
13%
Magnesium Oxide
12%
Proton Pump Inhibitor
10%
Ketamine
10%
Candesartan
9%
Essential Drug
8%
Sertraline
8%
Enalapril
8%
Serotonin
8%
Analgesic
7%
Neuroprotective
7%
Monoamine
7%
Cefepime
6%
Communication
6%
Milnacipran
5%